Brief: Simulations Plus Announces Funded Collaboration With Pharmaceutical Firm
21/04/2022 13:39
April 21 (Reuters) - Simulations Plus Inc SLP.O :
* SIMULATIONS PLUS INC- ANNOUNCED A NEW FUNDED COLLABORATION
WITH
A LARGE PHARMACEUTICAL COMPANY
* SIMULATIONS PLUS- COLLABORATION TO EXPAND, VALIDATE
MECHANISTIC
IN VITRO DISSOLUTION MODELS FOR INTRAVITREAL INJECTABLE
FORMULATIONS WITHIN DDDPLUS SOFTWARE
Source text for Eikon: ID:nBw3DqcK3a
Further company coverage: SLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simulations Plus
See all newsBrief: Simulations Plus Altaris To Pay $26 Million Termination Fee To Co If Merger Agreement Terminated
NASDAQ RESUMED AT 09:55 AM
Brief: Simulations Plus To Be Acquired By Altaris For Approximately $375 Million
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
Simulations Plus Q2 results beat expectations but lowers annual profit forecast on tax rate jump